170844-49-2 Usage
General Description
Ethyl 1-Boc-3-pyrrolidinecarboxylate is a chemical compound used in organic synthesis and pharmaceutical research. It is an ester derivative of the amino acid pyrrolidine and contains a tert-butoxycarbonyl (Boc) protecting group. Ethyl 1-Boc-3-pyrrolidinecarboxylate is commonly used as a building block in the production of various pharmaceuticals, including antiviral and anticancer drugs. It is known for its ability to selectively modify specific functional groups in organic molecules, making it a valuable tool in the development of new drug candidates. In addition, it is also used in the preparation of chiral ligands and catalysts for asymmetric synthesis. Ethyl 1-Boc-3-pyrrolidinecarboxylate is considered a versatile and important chemical in the field of organic chemistry and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 170844-49-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,0,8,4 and 4 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 170844-49:
(8*1)+(7*7)+(6*0)+(5*8)+(4*4)+(3*4)+(2*4)+(1*9)=142
142 % 10 = 2
So 170844-49-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H21NO4/c1-5-16-10(14)9-6-7-13(8-9)11(15)17-12(2,3)4/h9H,5-8H2,1-4H3
170844-49-2Relevant articles and documents
JAK INHIBITOR
-
Paragraph 0188; 0189; 0190, (2017/12/15)
The present invention discloses a series of JAK inhibitors, and particularly discloses a compound of formula (I) or a pharmaceutically acceptable salt thereof and the use thereof in preparation of drugs for treating diseases related to JAK.
COMPOUNDS AND COMPOSITIONS FOR COGNITION-ENHANCEMENT, METHODS OF MAKING, AND METHODS OF TREATING
-
Page/Page column 137, (2011/08/03)
Disclosed are muscarinic agonist compounds including oxadiazole derivatives, compositions and preparations thereof. Also disclosed are methods of synthesizing such oxadiazole compounds. Further disclosed are methods for treating a subject with said muscarinic agonists or a pharmaceutically suitable form thereof to enhance cognitive function.
QUINOLONE ANTIBACTERIAL AGENTS
-
Page/Page column 89; 90; 130, (2010/02/12)
Compounds of formula (I) wherein A is formula (II), formula (III) or formula (IV), and B is formula (V), formula (VI), or formula (VII), can be used in a variety of applications including use as antibacterial agents.
